Accrual and Treatment
DISEASE
The sensitive study enrolled all 41 patients between December 9, 2009 and February 12, 2012. The resistant study enrolled 46 of the planned 48 patients between December 11, 2009 and December 16, 2012, and 1 patient though enrolled, did not receive any study medication. Sixteen patients (39%) with sensitive disease continued iniparib as maintenance therapy. This number was only 8 (18%) for resistant patients. Demographics are shown in Demographics.
